Hu Y - Search Results

1

Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors.

Zhan W, Li D, Che J, Zhang L, Yang B, Hu Y, Liu T, Dong X. Zhan W, et al. Among authors: hu y. Eur J Med Chem. 2014 Mar 21;75:11-20. doi: 10.1016/j.ejmech.2014.01.019. Epub 2014 Jan 22. Eur J Med Chem. 2014. PMID: 24508830

2

Nitrogen-containing flavonoids as CDK1/Cyclin B inhibitors: design, synthesis, and biological evaluation.

Liu T, Xu Z, He Q, Chen Y, Yang B, Hu Y. Liu T, et al. Among authors: hu y. Bioorg Med Chem Lett. 2007 Jan 1;17(1):278-81. doi: 10.1016/j.bmcl.2006.07.088. Epub 2006 Nov 7. Bioorg Med Chem Lett. 2007. PMID: 17085048

3

Synthesis and anticancer activity of a novel class of flavonoids: 2,4-diarylchromane[4,3-d]-delta(1,9b)-1,2,3-thiadiazolines.

Ying H, Hu Y, He Q, Li R, Yang B. Ying H, et al. Among authors: hu y. Eur J Med Chem. 2007 Feb;42(2):226-34. doi: 10.1016/j.ejmech.2006.10.004. Epub 2006 Nov 28. Eur J Med Chem. 2007. PMID: 17137679

4

Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors.

Jia P, Sheng R, Zhang J, Fang L, He Q, Yang B, Hu Y. Jia P, et al. Among authors: hu y. Eur J Med Chem. 2009 Feb;44(2):772-84. doi: 10.1016/j.ejmech.2008.04.018. Epub 2008 May 4. Eur J Med Chem. 2009. PMID: 18550228

5

Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.

Dong X, Liu Y, Yan J, Jiang C, Chen J, Liu T, Hu Y. Dong X, et al. Among authors: hu y. Bioorg Med Chem. 2008 Sep 1;16(17):8151-60. doi: 10.1016/j.bmc.2008.07.031. Epub 2008 Jul 20. Bioorg Med Chem. 2008. PMID: 18678502

6

Synthesis and biological evaluation of novel flavonoid derivatives as dual binding acetylcholinesterase inhibitors.

Shen Y, Zhang J, Sheng R, Dong X, He Q, Yang B, Hu Y. Shen Y, et al. Among authors: hu y. J Enzyme Inhib Med Chem. 2009 Apr;24(2):372-80. doi: 10.1080/14756360802187885. J Enzyme Inhib Med Chem. 2009. PMID: 18830885 Free article.

7

Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents.

Dong X, Liu T, Yan J, Wu P, Chen J, Hu Y. Dong X, et al. Among authors: hu y. Bioorg Med Chem. 2009 Jan 15;17(2):716-26. doi: 10.1016/j.bmc.2008.11.052. Epub 2008 Nov 24. Bioorg Med Chem. 2009. PMID: 19070497

8

PI3K inhibitors for cancer therapy: what has been achieved so far?

Wu P, Liu T, Hu Y. Wu P, et al. Among authors: hu y. Curr Med Chem. 2009;16(8):916-30. doi: 10.2174/092986709787581905. Curr Med Chem. 2009. PMID: 19275602

9

Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives.

Chen J, Dong X, Liu T, Lou J, Jiang C, Huang W, He Q, Yang B, Hu Y. Chen J, et al. Among authors: hu y. Bioorg Med Chem. 2009 May 1;17(9):3324-31. doi: 10.1016/j.bmc.2009.03.037. Epub 2009 Mar 26. Bioorg Med Chem. 2009. PMID: 19359185

10

QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.

Dong X, Jiang C, Hu H, Yan J, Chen J, Hu Y. Dong X, et al. Among authors: hu h, hu y. Eur J Med Chem. 2009 Oct;44(10):4090-7. doi: 10.1016/j.ejmech.2009.04.050. Epub 2009 May 15. Eur J Med Chem. 2009. PMID: 19497644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,210 results

Search Page

Filters